Meda AB (publ) AGM bulletin

Meda AB (publ) AGM bulletin

At the annual general meeting (AGM) on 5 May 2009, shareholders of Meda AB
(publ), corporate ID 556427-2812, Box 906, 170 09 Solna, resolved that a
dividend of SEK 0.75 per share be issued for fiscal year 2008.

The AGM adopted the income statement, balance sheet, consolidated income
statement, and consolidated balance sheet. The AGM also discharged the board and
CEO from liability.

All proposals from the nomination committee were adopted. The board's proposed
guidelines for group executives were adopted. The AGM also resolved to adopt the
board's proposal to authorize the board to decide on new share issues.

Complete details of all AGM resolutions are available at Meda's head office at
Pipers väg 2A, Solna, Sweden. Phone: +46 8 630 19 00. They will be sent upon
request and without cost to shareholders that provide an address. AGM
resolutions will also be available at www.meda.se.

The board of Meda AB


For more information contact:

Anders Larnholt, VP Corporate Development & Investor Relations	tel. +46 709 458
878

MEDA AB (publ) is a leading international specialty pharma company. The company
specialises in marketing and pharmaceutical development in late clinical stage.
Acquisitions and long-term partnerships drive the company's strategy. Meda is
represented by its own organizations in about 40 countries. Meda's products are
sold in 120 countries worldwide. The Meda share is listed under Large Cap on the
Nasdaq OMX Nordic Stock Exchange Stockholm. Find out more, visit www.meda.se.